Inventor
BRAMELD KENNETH ALBERT
US19 patents
⚠️ This page may combine multiple inventors who share the name “BRAMELD KENNETH ALBERT”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
PRINCIPIA BIOPHARMA INC
16 patentsUS8957080B2Feb 17, 2015
Tyrosine kinase inhibitors
PRINCIPIA BIOPHARMA INC19 citations92
US9815834B2Nov 14, 2017
Quinolone derivatives as fibroblast growth factor receptor inhibitors
PRINCIPIA BIOPHARMA INC4 citations84
US9567334B2Feb 14, 2017
Quinolone derivatives as fibroblast growth factor receptor inhibitors
PRINCIPIA BIOPHARMA INC6 citations84
US11078199B2Aug 3, 2021
Quinolone derivatives as fibroblast growth factor receptor inhibitors
PRINCIPIA BIOPHARMA INC2 citations73
US10538517B2Jan 21, 2020
Quinolone derivatives as FGFR inhibitors
PRINCIPIA BIOPHARMA INC3 citations73
US10294223B2May 21, 2019
Quinolone derivatives as fibroblast growth factor receptor inhibitors
PRINCIPIA BIOPHARMA INC2 citations73
US9630963B2Apr 25, 2017
Quinolone derivatives as fibroblast growth factor inhibitors
PRINCIPIA BIOPHARMA INC3 citations73
US11827656B2Nov 28, 2023
Immunoproteasome inhibitors
PRINCIPIA BIOPHARMA INC2 citations71
US11225493B2Jan 18, 2022
Immunoproteasome inhibitors
PRINCIPIA BIOPHARMA INC4 citations71
US12162882B2Dec 10, 2024
Quinolone derivatives as fibroblast growth factor receptor inhibitors
PRINCIPIA BIOPHARMA INC0 citations62
US12312370B2May 27, 2025
Immunoproteasome inhibitors
PRINCIPIA BIOPHARMA INC0 citations61
US11154563B2Oct 26, 2021
Immunoproteasome inhibitors
PRINCIPIA BIOPHARMA INC2 citations61
US9676778B2Jun 13, 2017
Substituted pyrrolo[2,3-b]pyrazines as JAK3 inhibitors
PRINCIPIA BIOPHARMA INC1 citations51
US12024531B2Jul 2, 2024
Immunoproteasome inhibitors
PRINCIPIA BIOPHARMA INC0 citations50
US10654843B2May 19, 2020
LMP7 inhibitors
PRINCIPIA BIOPHARMA INC0 citations40
US9573958B2Feb 21, 2017
Benzimidazole derivatives as ITK inhibitors
PRINCIPIA BIOPHARMA INC0 citations40